FEATURED COMPANIES
- AbbVie Inc.
- Asahi Kasei Corp.
- Biocon Ltd.
- Cadila Healthcare Ltd.
- Mylan NV
- Novartis AG
- MORE
Global Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, and Others), By Transplant Organ (Heart, Kidney, Lung, and Others), By Drug Type (Generic & Branded), Forecast 2020-2026.
The global organ transplant immunosuppressant drug market is anticipated to grow at a CAGR 14% during the forecast period. A wide range of immunosuppressant drugs is used after the organ transplant to reduce the chances of organ rejection by the body. Immunosuppressant drugs also aid in preventing the newly transfer organ form the various infections. Hence, increasing demand for organ transplants across the globe is expected to significantly drive the organ transplant immunosuppressant drug market during the forecast period. However, the high cost of organ transplants and its drugs is one of the major restraints for the market, especially in emerging economies.
The global organ transplant immunosuppressant drugs market is segmented based on the drug class, transplant organ, and drug type. Based on the drug class, the market is sub-segmented into calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and others. Further, based on transplant organ, the market is sub-segmented into the heart, kidney, lung, and others. By drug type, the market is bifurcated into generic and patented drugs.
The global organ transplant immunosuppressant drugs market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to have a major market share during the forecast period. It is due to the increasing organ transplant across the region. For instance, according to the United Network for Organ Sharing (UNOS), in 2019, around 40,000 organs were transplanted alone in the US.
The key players of the global organ transplant immunosuppressant drugs market include Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Neovii Pharmaceuticals AG, Novartis AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including merger, and acquisition, collaborations with government, funding, and new drug launches to stay competitive in the market.
Research Methodology
The market study of the global organ transplant immunosuppressant drugs market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to brings added value to the reports.
Secondary Sources Include
Market Segmentation
The global organ transplant immunosuppressant drug market is anticipated to grow at a CAGR 14% during the forecast period. A wide range of immunosuppressant drugs is used after the organ transplant to reduce the chances of organ rejection by the body. Immunosuppressant drugs also aid in preventing the newly transfer organ form the various infections. Hence, increasing demand for organ transplants across the globe is expected to significantly drive the organ transplant immunosuppressant drug market during the forecast period. However, the high cost of organ transplants and its drugs is one of the major restraints for the market, especially in emerging economies.
The global organ transplant immunosuppressant drugs market is segmented based on the drug class, transplant organ, and drug type. Based on the drug class, the market is sub-segmented into calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and others. Further, based on transplant organ, the market is sub-segmented into the heart, kidney, lung, and others. By drug type, the market is bifurcated into generic and patented drugs.
The global organ transplant immunosuppressant drugs market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to have a major market share during the forecast period. It is due to the increasing organ transplant across the region. For instance, according to the United Network for Organ Sharing (UNOS), in 2019, around 40,000 organs were transplanted alone in the US.
The key players of the global organ transplant immunosuppressant drugs market include Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Neovii Pharmaceuticals AG, Novartis AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including merger, and acquisition, collaborations with government, funding, and new drug launches to stay competitive in the market.
Research Methodology
The market study of the global organ transplant immunosuppressant drugs market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to brings added value to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
Market Segmentation
- Global Organ Transplant Immunosuppressant Drugs Market Research and Analysis, By Drug Class
- Global Organ Transplant Immunosuppressant Drugs Market Research and Analysis, By Transplant Organ
- Global Organ Transplant Immunosuppressant Drugs Market Research and Analysis, By Drug Type
- Comprehensive research methodology of the Global Organ Transplant Immunosuppressant Drugs Market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Organ Transplant Immunosuppressant Drugs Market.
- Insights about market determinants which are stimulating the Global Organ Transplant Immunosuppressant Drugs Industry.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AbbVie Inc.
- Asahi Kasei Corp.
- Biocon Ltd.
- Cadila Healthcare Ltd.
- Mylan NV
- Novartis AG
- MORE
1. Report Summary
1.1. Research Business Functions and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Astellas Pharma Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Bristol-Myers Squibb Company
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. F. Hoffmann-La Roche Ltd.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Neovii Pharmaceuticals AG
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Novartis AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Organ Transplant Immunosuppressant Drugs Market by Drug Class
5.1.1. Calcineurin Inhibitors
5.1.2. Antiproliferative Agents
5.1.3. mTOR Inhibitor
5.1.4. Steroids
5.1.5. Others
5.2. Global Organ Transplant Immunosuppressant Drugs Market by Transplant Organ
5.2.1. Heart
5.2.2. Kidney
5.2.3. Lung
5.2.4. Others
5.3. Global Organ Transplant Immunosuppressant Drugs Market by Drug Type
5.3.1. Patented
5.3.2. Generic
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Accord Healthcare Ltd. (Intas Pharmaceuticals Ltd.)
7.3. Allnatt Pharma LLP
7.4. Asahi Kasei Corp.
7.5. Astellas Pharma Inc.
7.6. Biocon Ltd.
7.7. Bristol-Myers Squibb Co.
7.8. Cadila Healthcare Ltd.
7.9. Dr. Reddy’s Laboratories Ltd.
7.10. F. Hoffmann-La Roche Ltd.
7.11. Mylan NV
7.12. Neovii Pharmaceuticals AG
7.13. Novartis AG
7.14. Pfizer Inc.
7.15. Sanofi SA
7.16. Swiss Pharma Pvt. Ltd.
7.17. Teva Pharmaceutical Industries Ltd.
7.18. Veloxis Pharmaceuticals, Inc.
LIST OF TABLES
1. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
2. GLOBAL CALCINEURIN INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL ANTIPROLIFERATIVE AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL mTOR INHIBITOR MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL STEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
8. GLOBAL HEART IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL KIDNEY IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL LIVER IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL OTHERS IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
13. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
14. GLOBAL PATENTED MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL GENERIC MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. NORTH AMERICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
18. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
19. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
20. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
21. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
22. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
23. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
24. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
25. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
27. ASIA PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
28. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
29. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
30. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
LIST OF FIGURES
1. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY DRUG CLASS, 2019 VS 2026 (%)
2. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY TRANSPLANT ORGAN, 2019 VS 2026 (%)
3. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
4. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. US ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
7. UK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
17. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
1.1. Research Business Functions and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Astellas Pharma Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Bristol-Myers Squibb Company
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. F. Hoffmann-La Roche Ltd.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Neovii Pharmaceuticals AG
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Novartis AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Organ Transplant Immunosuppressant Drugs Market by Drug Class
5.1.1. Calcineurin Inhibitors
5.1.2. Antiproliferative Agents
5.1.3. mTOR Inhibitor
5.1.4. Steroids
5.1.5. Others
5.2. Global Organ Transplant Immunosuppressant Drugs Market by Transplant Organ
5.2.1. Heart
5.2.2. Kidney
5.2.3. Lung
5.2.4. Others
5.3. Global Organ Transplant Immunosuppressant Drugs Market by Drug Type
5.3.1. Patented
5.3.2. Generic
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Accord Healthcare Ltd. (Intas Pharmaceuticals Ltd.)
7.3. Allnatt Pharma LLP
7.4. Asahi Kasei Corp.
7.5. Astellas Pharma Inc.
7.6. Biocon Ltd.
7.7. Bristol-Myers Squibb Co.
7.8. Cadila Healthcare Ltd.
7.9. Dr. Reddy’s Laboratories Ltd.
7.10. F. Hoffmann-La Roche Ltd.
7.11. Mylan NV
7.12. Neovii Pharmaceuticals AG
7.13. Novartis AG
7.14. Pfizer Inc.
7.15. Sanofi SA
7.16. Swiss Pharma Pvt. Ltd.
7.17. Teva Pharmaceutical Industries Ltd.
7.18. Veloxis Pharmaceuticals, Inc.
LIST OF TABLES
1. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
2. GLOBAL CALCINEURIN INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL ANTIPROLIFERATIVE AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL mTOR INHIBITOR MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL STEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
8. GLOBAL HEART IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL KIDNEY IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL LIVER IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL OTHERS IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
13. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
14. GLOBAL PATENTED MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL GENERIC MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. NORTH AMERICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
18. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
19. NORTH AMERICAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
20. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
21. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
22. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
23. EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
24. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
25. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
27. ASIA PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
28. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
29. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY TRANSPLANT ORGAN, 2019-2026 ($ MILLION)
30. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
LIST OF FIGURES
1. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY DRUG CLASS, 2019 VS 2026 (%)
2. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY TRANSPLANT ORGAN, 2019 VS 2026 (%)
3. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
4. GLOBAL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. US ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
7. UK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
17. REST OF THE WORLD ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
Note: Product cover images may vary from those shown
- AbbVie Inc.
- Accord Healthcare Ltd. (Intas Pharmaceuticals Ltd.)
- Allnatt Pharma LLP
- Asahi Kasei Corp.
- Astellas Pharma Inc.
- Biocon Ltd.
- Bristol-Myers Squibb Co.
- Cadila Healthcare Ltd.
- Dr. Reddy’s Laboratories Ltd.
- F. Hoffmann-La Roche Ltd.
- Mylan NV
- Neovii Pharmaceuticals AG
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Swiss Pharma Pvt. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Veloxis Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
